Cognios Beta Neutral Large Cap Fund’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$557K Sell
4,225
-945
-18% -$116K 0.73% 34
2023
Q4
$564K Sell
5,170
-452
-8% -$46.9K 0.74% 49
2023
Q3
$579K Sell
5,622
-1,040
-16% -$112K 0.75% 55
2023
Q2
$769K Sell
6,662
-3,281
-33% -$373K 0.89% 34
2023
Q1
$1.05M Buy
9,943
+489
+5% +$52.8K 1% 26
2022
Q4
$1.05M Buy
+9,454
New +$966K 1.01% 26

Other funds holding MRK

Cognios Beta Neutral Large Cap Fund's MRK Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund reduced its Merck (MRK) stake by 18% in Q1 2024, selling an estimated $116K and leaving 4,225 shares worth $557K. The position accounts for 0.73% of the portfolio, ranked #34.

Cognios Beta Neutral Large Cap Fund first reported a position in MRK in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.05M in Q1 2023. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Cognios Beta Neutral Large Cap Fund held 4,225 shares of Merck worth $557K as of Q1 2024.
  • Cognios Beta Neutral Large Cap Fund sold 945 Merck shares in Q1 2024, an estimated $116K.
  • Merck made up 0.73% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #34 holding.
  • Cognios Beta Neutral Large Cap Fund first reported a position in Merck in Q4 2022 and has held it in 6 quarters since.
  • Cognios Beta Neutral Large Cap Fund's Merck position peaked at $1.05M in Q1 2023.
  • 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.